Sun Pharma.Inds. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
15,118.00
13,752.00
11,087.00
9,408.00
4,481.00
2,799.00
Adjustment
882.00
1,120.00
1,554.00
2,722.00
1,974.00
1,809.00
Changes In working Capital
-1,267.00
-323.00
1,062.00
-5,661.00
1,559.00
2,564.00
Cash Flow after changes in Working Capital
14,733.00
14,548.00
13,704.00
6,469.00
8,015.00
7,173.00
Cash Flow from Operating Activities
12,419.00
14,072.00
12,134.00
4,959.00
8,984.00
6,170.00
Cash Flow from Investing Activities
-10,404.00
-5,183.00
-762.00
-7,219.00
-5,555.00
406.00
Cash Flow from Financing Activities
-2,512.00
-7,905.00
-6,710.00
2,376.00
-5,193.00
-5,980.00
Net Cash Inflow / Outflow
-498.00
983.00
4,661.00
115.00
-1,764.00
596.00
Opening Cash & Cash Equivalents
10,268.00
9,285.00
4,623.00
4,508.00
6,273.00
5,676.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
9,770.00
10,268.00
9,285.00
4,623.00
4,508.00
6,273.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sun Pharma.Inds.
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
15118.88
2916
12,202.00
418.48%
Adjustment
882.03
115
767.00
666.98%
Changes In working Capital
-1267.79
-554
-713.00
-128.84%
Cash Flow after changes in Working Capital
14733.12
2477
12,256.00
494.80%
Cash Flow from Operating Activities
12419.18
1653
10,766.00
651.31%
Cash Flow from Investing Activities
-10404.89
-804
-9,600.00
-1194.14%
Cash Flow from Financing Activities
-2512.55
-799
-1,713.00
-214.46%
Net Cash Inflow / Outflow
-498.26
50
-548.00
-1096.52%
Opening Cash & Cash Equivalents
10268.77
363
9,905.00
2728.86%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
9770.51
413
9,357.00
2265.74%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -11.75% vs 15.96% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
12,419.18
14,072.09
-11.75%






